An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers
Clinical trial NCT02648490 · COMPLETED
Trial details
- NCT number
- NCT02648490
- Sponsor
- Henlix, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2019-06-28
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.